dronabinol has been researched along with Brain Inflammation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia-Segura, LM; Llorente-Berzal, A; Lopez-Rodriguez, AB; Viveros, MP | 1 |
| Fishbein-Kaminietsky, M; Gafni, M; Sarne, Y | 1 |
| Gabaglio, M; Parolaro, D; Prini, P; Rubino, T; Zamberletti, E | 1 |
| Del Giudice, E; Facchinetti, F; Furegato, S; Leon, A; Passarotto, M | 1 |
| Diamond, M; Finn, DP; Kelly, JP; Roche, M | 1 |
| Lavie, G; Leker, RR; Ovadia, H; Shohami, E; Teichner, A | 1 |
6 other study(ies) available for dronabinol and Brain Inflammation
| Article | Year |
|---|---|
Sex-dependent long-term effects of adolescent exposure to THC and/or MDMA on neuroinflammation and serotoninergic and cannabinoid systems in rats.
Topics: Adolescent; Animals; Calcium-Binding Proteins; Cannabinoids; Dronabinol; Encephalitis; Female; Glial Fibrillary Acidic Protein; Humans; Male; Microfilament Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Serotonin; Sex Factors | 2014 |
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage.
Topics: Anilides; Animals; Arachidonic Acids; Brain; Camphanes; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cognition Disorders; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Encephalitis; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; PPAR gamma; Pyrazoles; Recognition, Psychology | 2014 |
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.
Topics: Age Factors; Animals; Animals, Newborn; Cognition Disorders; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Dronabinol; Encephalitis; Female; Gene Expression Regulation; Hallucinogens; Immobility Response, Tonic; Interpersonal Relations; Nitric Oxide Synthase Type II; Phosphodiesterase Inhibitors; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Swimming | 2015 |
Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Arachidonic Acids; Benzoxazines; Brain; Cannabinoids; Cells, Cultured; Cyclohexanols; Dronabinol; Encephalitis; Endocannabinoids; Glycerides; Inflammation Mediators; Microglia; Morpholines; Naphthalenes; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; RNA, Messenger; Tumor Necrosis Factor-alpha | 2003 |
In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids.
Topics: Animals; Camphanes; Corticosterone; Dronabinol; Drug Interactions; Encephalitis; Hypothalamo-Hypophyseal System; Interferon-gamma; Interleukin-10; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Lymphocyte Count; Male; Neuroimmunomodulation; Neuroprotective Agents; Piperidines; Pituitary-Adrenal System; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Tumor Necrosis Factor-alpha | 2006 |
Long term cerebroprotective effects of dexanabinol in a model of focal cerebral ischemia.
Topics: Animals; Body Weight; Brain Ischemia; Cardiovascular Physiological Phenomena; Cerebral Cortex; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Encephalitis; Free Radicals; Infarction, Middle Cerebral Artery; Male; Movement Disorders; Nerve Degeneration; Neurons; Neuroprotective Agents; Rats; Rats, Inbred SHR; Tetrazolium Salts | 2001 |